chr15-40729955-G-A
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_002875.5(RAD51):c.877G>A(p.Ala293Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. A293A) has been classified as Likely benign.
Frequency
Consequence
NM_002875.5 missense
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group RInheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- mirror movements 2Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- familial congenital mirror movementsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary breast carcinomaInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RAD51 | ENST00000267868.8 | c.877G>A | p.Ala293Thr | missense_variant | Exon 9 of 10 | 1 | NM_002875.5 | ENSP00000267868.3 | ||
| RAD51 | ENST00000532743.6 | c.877G>A | p.Ala293Thr | missense_variant | Exon 9 of 10 | 2 | ENSP00000433924.2 | |||
| RAD51 | ENST00000557850.5 | c.586G>A | p.Ala196Thr | missense_variant | Exon 7 of 8 | 2 | ENSP00000454176.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
RAD51-related disorder Pathogenic:2
The RAD51 c.880G>A variant is predicted to result in the amino acid substitution p.Ala294Thr. This variant has been reported as arising de novo in an individual with microcephaly and intellectual disability, and described as atypical Fanconi anemia (reported as p.Ala293Thr in alternate transcript NM_002875 in Ameziane et al. 2015. PubMed ID: 26681308). Functional studies from this same report using protein expression in cultured cells indicate that the p.Ala294Thr substitution has a dominant negative effect on the wild-type protein (Ameziane et al. 2015. PubMed ID: 26681308). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Given the evidence, we interpret c.880G>A (p.Ala294Thr) as likely pathogenic. -
This variant has been previously reported as a de novo alteration in a patient with an atypical Fanconi Anemia who presented with growth retardation, microcephaly, hydrocephalus, skeletal (thumb and radius) abnormalities, imperforate anus and an improperly formed left testicle (NM_002875.3: c.877G>A, p.A293T; PMID: 26681308). In vitro characterization of this alteration via functional assays and biochemical studies demonstrated that the variant acts in a dominant-negative manner leading to impaired DNA binding and strand exchange activity as well as impaired ATP hydrolysis. Furthermore, patient's cells were sensitive to DNA crosslinking agents (PMID: 26681308). The c.880G>A p.Ala294Thr variant is absent from the gnomAD population database and thus is presumed to be rare. It affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.880G>A (p.Ala294Thr) variant is classified as Pathogenic. -
Inborn genetic diseases Pathogenic:1
- -
Fanconi anemia complementation group R Pathogenic:1
- -
not provided Uncertain:1
Curator: Arleen D. Auerbach. Submitter to LOVD: Najim Ameziane. Comment: Variant observed de novo. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at